Department of Neurology, Neurocritical Care Unit, University Hospital, Innsbruck, Austria.
Neurocrit Care. 2011 Sep;15(2):281-6. doi: 10.1007/s12028-011-9601-0.
Although metabolic abnormalities have been linked with poor outcome after subarachnoid hemorrhage, there are limited data addressing the impact of glycemic control or benefits of glucose management after aneurysmal subarachnoid hemorrhage. A systematic literature search was conducted of English-language articles describing original research on glycemic control in patients with subarachnoid hemorrhage. Case reports and case series were excluded. A total of 22 publications were selected for this review. Among the 17 studies investigating glucose as an outcome predictor, glucose levels during hospitalization were more likely to predict outcome than admission glucose. In general, hyperglycemia was linked to worse outcome. While insulin therapy in subarachnoid hemorrhage patients was shown to effectively control plasma glucose levels, plasma glucose control was not necessarily reflective of cerebral glucose such that very tight glucose control may lead to neuroglycopenia. Furthermore, tight glycemic control was associated with an increased risk for hypoglycemia which was linked to worse outcome.
尽管代谢异常与蛛网膜下腔出血后预后不良有关,但关于血糖控制或葡萄糖管理对动脉瘤性蛛网膜下腔出血后患者的影响的数据有限。对描述蛛网膜下腔出血患者血糖控制的原始研究的英文文献进行了系统的文献检索。排除病例报告和病例系列。本综述共选择了 22 篇出版物。在 17 项研究葡萄糖作为预后预测因子的研究中,住院期间的血糖水平比入院时的血糖更有可能预测结果。一般来说,高血糖与预后不良有关。虽然蛛网膜下腔出血患者的胰岛素治疗被证明可以有效控制血糖水平,但血糖控制并不一定反映脑葡萄糖水平,因此非常严格的血糖控制可能导致神经低血糖。此外,严格的血糖控制与低血糖风险增加有关,而低血糖与预后不良有关。